Clinical Trial Update: Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial evaluating botulinum toxin type A injections to treat habitual snoring has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Habitual Snoring

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Habitual Snoring | Phase 2 | Status: TERMINATED